EZH2 silencing combined with ATRA treatment resulted in a greater suppression of cell growth and colony formation in both BCC and cSCC cells, compared to single manipulations (Fig. 6F,G; Fig. S6f–i). This evidence concerns the gene EZH2 and skin basal cell carcinoma.